Josephs Paul 4

What Happened Paul Josephs, CEO of Lifecore Biomedical, had 40,413 shares withheld by the company on May 20, 2026 to satisfy tax withholding related to RSU vesting. The shares were valued at $4.57 each, totaling roughly $184,687. This was a tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date and price: May 20, 2026; 40,413 shares at $4.57 each (≈ $184,687).
• Filing date: May 21, 2026 (covers the May 20 transaction); appears to be timely.
• Shares owned after transaction: Not specified in the Form 4 provided.
• Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding obligations in connection with RSU vesting.
• Transaction type: Tax withholding/cashless settlement of RSUs (disposition for tax purposes, not a market sale).

Context This is a routine tax-withholding event that occurs when restricted stock units vest and the company retains shares to cover withholding obligations. Such transactions are administrative and do not necessarily signal insider buying or selling intent in the open market.